These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 26754790)

  • 1. Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 1: Cysteine Residues and Glycans.
    Adumeau P; Sharma SK; Brent C; Zeglis BM
    Mol Imaging Biol; 2016 Feb; 18(1):1-17. PubMed ID: 26754790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 2: Peptide Tags and Unnatural Amino Acids.
    Adumeau P; Sharma SK; Brent C; Zeglis BM
    Mol Imaging Biol; 2016 Apr; 18(2):153-65. PubMed ID: 26754791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-specific bioconjugation and nuclear imaging.
    Sebastiano J; Samuels ZV; Kao WS; Zeglis BM
    Curr Opin Chem Biol; 2024 Aug; 81():102471. PubMed ID: 38833913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging.
    Zeglis BM; Davis CB; Abdel-Atti D; Carlin SD; Chen A; Aggeler R; Agnew BJ; Lewis JS
    Bioconjug Chem; 2014 Dec; 25(12):2123-8. PubMed ID: 25418333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of Glycans-Specific Bioconjugation on the FcγRI Binding and
    Vivier D; Fung K; Rodriguez C; Adumeau P; Ulaner GA; Lewis JS; Sharma SK; Zeglis BM
    Theranostics; 2020; 10(4):1746-1757. PubMed ID: 32042334
    [No Abstract]   [Full Text] [Related]  

  • 6. Site-specific chelator-antibody conjugation for PET and SPECT imaging with radiometals.
    Morais M; Ma MT
    Drug Discov Today Technol; 2018 Dec; 30():91-104. PubMed ID: 30553525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretargeted PET Imaging Using a Site-Specifically Labeled Immunoconjugate.
    Cook BE; Adumeau P; Membreno R; Carnazza KE; Brand C; Reiner T; Agnew BJ; Lewis JS; Zeglis BM
    Bioconjug Chem; 2016 Aug; 27(8):1789-95. PubMed ID: 27356886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer.
    Houghton JL; Zeglis BM; Abdel-Atti D; Aggeler R; Sawada R; Agnew BJ; Scholz WW; Lewis JS
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15850-5. PubMed ID: 26668398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular imaging based on metabolic glycoengineering and bioorthogonal click chemistry.
    Yoon HY; Koo H; Kim K; Kwon IC
    Biomaterials; 2017 Jul; 132():28-36. PubMed ID: 28399460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates.
    Davydova M; Dewaele Le Roi G; Adumeau P; Zeglis BM
    J Vis Exp; 2019 Mar; (145):. PubMed ID: 30907883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-Specifically Labeled Antibody-Drug Conjugate for Simultaneous Therapy and ImmunoPET.
    Adumeau P; Vivier D; Sharma SK; Wang J; Zhang T; Chen A; Agnew BJ; Zeglis BM
    Mol Pharm; 2018 Mar; 15(3):892-898. PubMed ID: 29356543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging.
    Mandikian D; Rafidi H; Adhikari P; Venkatraman P; Nazarova L; Fung G; Figueroa I; Ferl GZ; Ulufatu S; Ho J; McCaughey C; Lau J; Yu SF; Prabhu S; Sadowsky J; Boswell CA
    MAbs; 2018; 10(8):1269-1280. PubMed ID: 30199303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-Specific Antibody Conjugation for ADC and Beyond.
    Zhou Q
    Biomedicines; 2017 Nov; 5(4):. PubMed ID: 29120405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current methods for the synthesis of homogeneous antibody-drug conjugates.
    Sochaj AM; Świderska KW; Otlewski J
    Biotechnol Adv; 2015 Nov; 33(6 Pt 1):775-84. PubMed ID: 25981886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of Site-Specific Radiolabeled Antibodies for Radioimmunotherapy via Genetic Code Expansion.
    Wu Y; Zhu H; Zhang B; Liu F; Chen J; Wang Y; Wang Y; Zhang Z; Wu L; Si L; Xu H; Yao T; Xiao S; Xia Q; Zhang L; Yang Z; Zhou D
    Bioconjug Chem; 2016 Oct; 27(10):2460-2468. PubMed ID: 27617674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homogeneous Antibody-Drug Conjugates via Glycoengineering.
    Tang F; Shi W; Huang W
    Methods Mol Biol; 2019; 2033():221-238. PubMed ID: 31332757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of precision antibody conjugates using proximity-induced chemistry.
    Cao YJ; Yu C; Wu KL; Wang X; Liu D; Tian Z; Zhao L; Qi X; Loredo A; Chung A; Xiao H
    Theranostics; 2021; 11(18):9107-9117. PubMed ID: 34522229
    [No Abstract]   [Full Text] [Related]  

  • 18. Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development.
    Agarwal P; Bertozzi CR
    Bioconjug Chem; 2015 Feb; 26(2):176-92. PubMed ID: 25494884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-Specific
    Ahn SH; Vaughn BA; Solis WA; Lupher ML; Hallam TJ; Boros E
    Bioconjug Chem; 2020 Apr; 31(4):1177-1187. PubMed ID: 32138509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycans of Antibodies as a Specific Site for Drug Conjugation Using Glycosyltransferases.
    Qasba PK
    Bioconjug Chem; 2015 Nov; 26(11):2170-5. PubMed ID: 26065635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.